VIDO-InterVac

Vaccine and Infectious Disease Organization -
International Vaccine Centre

COVID-19 Updates

  • VIDO-InterVac COVID-19 vaccine to start toxicology studies

    Our work to develop and advance a COVID-19 vaccine candidate has progressed rapidly throughout the summer.

  • Making a difference: USask research centres help to combat COVID-19 pandemic

    Several University of Saskatchewan research centres are supporting the international effort to fight COVID-19 with some of the most advanced research tools Canada has to offer.

  • Uniquely USask: VIDO-InterVac a world-class research facility

    It is one of the largest and most advanced infectious disease research facilities in the world, with unique features that attract scientists from across the country and around the globe.

  • Video: Developing a vaccine for COVID-19

    Research technicians Jocelyne Lew and Shelby Landreth discuss how they are helping to develop a vaccine and test antivirals for COVID-19. They are members of a larger team working to advance solutions for this new virus (SARS-CoV-2).

  • VIDO-InterVac making progress on vaccine

    There are some promising early signs as researchers at the VIDO-InterVac develop a vaccine for COVID-19.

  • VIDO-InterVac team tackles coronavirus: Researchers developing prototype vaccines at USask

    As the world deals with the new pandemic, the novel coronavirus has become the No.1 priority for researchers VIDO-InterVac.

  • Video: Novel Coronavirus Research at VIDO-InterVac

    Dr. Volker Gerdts, director and CEO, discusses ongoing efforts at VIDO-InterVac to develop a vaccine for the novel coronavirus causing COVID-19.